Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advised Creades on its investment in Apotea
Mandate

Vinge advised Creades on its investment in Apotea

April 28, 2017

Creades AB (publ) (Nasdaq Stockholm) has purchased 4.9 per cent of the shares in Apolea Holding AB, which is the parent company (96.5%) of the Internet pharmacy Apotea AB.

The investment by Creades amounts to a total of SEK 120.5 million.
 
Vinges team consisted of Erik Sjöman and Jesper Ottergren.
 

Related

Vinge represents Alrik Technologies in connection with their latest funding round

 Vinge has represented Alrik Technologies in connection with their latest funding round led by People Ventures, with Pi Labs doubling down on their investment.
May 27, 2025

Vinge advises Trinax in connection with the acquisition of Struqtur

 Trinax, a Helix Kapital portfolio company, has acquired Struqtur, a Swedish company offering a comprehensive cloud-based software solution for time reporting, project management and work orders.
May 26, 2025

Vinge advises Viva Wine Group in connection with the acquisition of Delta Wines

 Vinge has acted as legal advisor to Viva Wine Group in connection with the acquisition of Delta Wines, a leading wine distributor in Europe. The transaction implies an enterprise value of approximately EUR 76 million on a cash and debt-free basis.
May 26, 2025